Results 271 to 280 of about 1,598,216 (309)
Some of the next articles are maybe not open access.
The Prevention of Type 2 Diabetes Mellitus
Endocrinology and Metabolism Clinics of North America, 2005With a worldwide pandemic of type 2 diabetes upon us, it is imperative that effective and practical preventive strategies be developed for this disease which, once established, carries with it excess morbidity and mortality. This article reviews recently published data on the prevention of type 2 diabetes and compares the demonstrated effectiveness of ...
Silvio E, Inzucchi, Robert S, Sherwin
openaire +2 more sources
Dyslipidemia in type 2 diabetes mellitus
Current Diabetes Reports, 2007Cardiovascular disease is a significant cause of morbidity and mortality in patients with diabetes mellitus (DM). DM is now recognized as a risk equivalent for coronary heart disease. The lipid profile in patients with type 2 DM is characterized by elevated triglycerides, low levels of high-density lipoprotein cholesterol, and small dense low-density ...
Ramprasad, Gadi, Frederick F, Samaha
openaire +2 more sources
Exercise for type 2 diabetes mellitus
Cochrane Database of Systematic Reviews, 2006Exercise is generally recommended for people with type 2 diabetes mellitus. However, some studies evaluate an exercise intervention including diet or behaviour modification or both, and the effects of diet and exercise are not differentiated. Some exercise studies involve low participant numbers, lacking power to show significant differences which may ...
Thomas, Diana +2 more
openaire +4 more sources
Pathogenesis of type 2 diabetes mellitus
Experimental and Clinical Endocrinology & Diabetes, 2001Type 2 diabetes mellitus is a heterogeneous disorder with genetic and acquired components. It is primarily due to impaired insulin secretion in that individuals with genetically impaired beta cell function cannot increase their insulin release sufficiently to compensate for insulin resistance.
J, Dostou, J, Gerich
openaire +2 more sources
Lixisenatide for type 2 diabetes mellitus
Expert Opinion on Investigational Drugs, 2011Type 2 diabetes mellitus (T2DM) is an increasing health problem worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists are an expanding drug class that target several of the pathophysiological traits of T2DM. Lixisenatide is a GLP-1 receptor agonist in development for once-daily treatment of T2DM.Pharmacological, preclinical and clinical evidence
Christensen, Mikkel +3 more
openaire +3 more sources
Dyslipidemia in type 2 diabetes mellitus
Nature Reviews Endocrinology, 2009Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus. The characteristic features of diabetic dyslipidemia are a high plasma triglyceride concentration, low HDL cholesterol concentration and increased concentration of small dense LDL-cholesterol particles.
openaire +2 more sources
Type 2 diabetes mellitus in adolescents
Current Opinion in Pediatrics, 2000Type 2 diabetes mellitus, a significant cause of adult morbidity and mortality, is being diagnosed more frequently in children and adolescents. Genetic predisposition and environmental factors are important determinants for the expression of this disease.
S T, Callahan, M J, Mansfield
openaire +2 more sources
Type 2 Diabetes Mellitus in Children
Endocrine Practice, 1998To provide an overview of type 2 diabetes in children and discuss short-term and long-term management strategies.We review the distinction among various types of diabetes mellitus as they apply to children. In addition, we discuss determining the precise diagnosis between the two major variants--type 1 and type 2 diabetes--and clinical management of ...
J H, Pohl, J A, Greer, K S, Hasan
openaire +2 more sources
Genetics of type 2 diabetes mellitus
Diabetes Research and Clinical Practice, 2005The clinical picture of type 2 diabetes mellitus (T2DM) is formed by impairment in insulin secretion and resistance to insulin action. As a result of intensive efforts of the scientists around the world mutations and polymorphisms in a number of genes were linked with monogenic and polygenic forms of T2DM.
openaire +2 more sources
Hyperuricaemia and type 2 diabetes mellitus
Clinical and Experimental Pharmacology and Physiology, 2018SummaryChoi et al reported the effect of hyperuricaemia on the new‐onset type 2 diabetes mellitus (T2DM). I present three queries. (i) Insulin is considered to stimulate uric acid reabsorption via specific transporter and the effect of hyperuricaemia on the new‐onset T2DM should be evaluated by considering insulin resistance. (ii) There is a limitation
openaire +2 more sources